 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848658
Online Users : 1226
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/15340
|
| Title: | Inhibitory perturbations of fluvastatin on afterhyperpolarization current, Erg-mediated K+ current, and hyperpolarization-activated cation current in both pituitary GH3 cells and primary embryonic mouse cortical neurons |
| Authors: | Wang, YJ;Yeh, CJ;Gao, ZH;Hwang, E;Chen, HH;Wu, SN |
| Contributors: | Center for Neuropsychiatric Research |
| Abstract: | Fluvastatin (FLV), the first synthetically derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, is a potent inhibitor of cholesterol biosynthesis. While its primary mechanism of action is to reduce cholesterol levels, there is some evidence suggesting that it may also have effects on K+ channels. However, the overall effects of fluvastatin on ionic currents are not yet well understood. The whole-cell clamp recordings were applied to evaluate the ionic currents and action potentials of cells. Here, we have demonstrated that FLV can effectively inhibit the amplitude of erg-mediated K+ current (IK(erg)) in pituitary tumor (GH3) cells, with an IC50 of approximately 3.2 µM. In the presence of FLV, the midpoint in the activation curve of IK(erg) was distinctly shifted to a less negative potential by 10 mV, with minimal modification of the gating charge. However, the magnitude of hyperpolarization-activated cation current (Ih) elicited by long-lasting membrane hyperpolarization was progressively decreased, with an IC50 value of 8.7 µM, upon exposure to FLV. More interestingly, we also found that FLV (5 µM) could regulate the action potential and afterhyperpolarization properties in primary embryonic mouse cortical neurons. Our study presents compelling evidence indicating that FLV has the potential to impact both the amplitude and gating of the ion channels IK(erg) and Ih. We also provide credible evidence suggesting that this drug has the potential to modify the properties of action potentials and the afterhyperpolarization current in electrically excitable cells. However, the assumption that these findings translate to similar in-vivo results remains unclear. |
| Date: | 2023-09-03 |
| Relation: | Neuroscience. 2023 Sep 03;531:12-23. |
| Link to: | http://dx.doi.org/10.1016/j.neuroscience.2023.08.038 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0306-4522&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:001081773800001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85171421009 |
| Appears in Collections: | [陳慧諴] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SCP85171421009.pdf | | 2121Kb | Adobe PDF | 81 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
